Caldwell Sutter Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Caldwell Sutter Capital's BIO Position: Q3 2026 in Review
Caldwell Sutter Capital held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2026 at 6 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #808.
Caldwell Sutter Capital first reported a position in BIO in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.28K in Q2 2023. 417 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Caldwell Sutter Capital held 6 shares of Bio-Rad Laboratories Class A worth $2.27K as of Q3 2026.
- Caldwell Sutter Capital left its Bio-Rad Laboratories Class A share count unchanged in Q3 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q3 2026, its #808 holding.
- Caldwell Sutter Capital first reported a position in Bio-Rad Laboratories Class A in Q2 2023 and has held it in 14 quarters since.
- Caldwell Sutter Capital's Bio-Rad Laboratories Class A position peaked at $2.28K in Q2 2023.
- 417 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Caldwell Sutter Capital's 13F filing for Q3 2026, filed 9 Nov 2026.